Venn Life Sciences Holdings PLC Posting of Annual Report & Notice of AGM (4883O)

TIDMVENN

RNS Number : 4883O

Venn Life Sciences Holdings PLC

28 May 2015

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Posting of Annual Report & Notice of AGM

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, confirms that the Annual Report and Accounts for the year ended 31 December 2014 ("2014 Annual Report and Accounts"), the Notice of the Annual General Meeting ("AGM") and a Form of Proxy have been posted to shareholders on 27(th) May 2015.

The AGM is to be held at 11am on 30 June 2015 at Finsgate, 5-7 Cranwood Street, London EC1 V9EE.

A copy of the 2014 Annual Report and Accounts and other documents are available on the Company's website: http://vennlifesciences.com/

Enquiries:

 
 Venn Life Sciences Holdings Plc                       www.vennlifesciences.com 
 Tony Richardson, Chief Executive                          Tel: +353 154 99 341 
  Officer 
 Orla McGuinness, Marketing Manager                          Tel: +33 676931178 
 
 Zeus Capital (Nominated Adviser 
  and Broker) 
 Ross Andrews/Andrew Jones                                   Tel: 0161 831 1512 
 Alex Davies                                                 Tel: 020 7533 7727 
 
 Walbrook PR Ltd                      Tel: 020 7933 8787 or venn@walbrookpr.com 
 Paul McManus                                                Mob: 07980 541 893 
 Lianne Cawthorne                                            Mob: 07584 391 303

About InnoVenn

InnoVenn (55.6% owned by Venn) is a market development accelerator dedicated to rapidly commercialising proven scientific breakthroughs in the form of products and technologies primarily in Skin Science. These include Labskin the breakthrough research grade human skin testing platform as well as the clinically proven Blemish Control Technology for the professional skincare market. For more information on Innovenn, visit www.innovenn.co.uk

About Venn Life Sciences Limited

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management solutions and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK and Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science. For more information, visit www.vennlifesciences.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DOCPGUPGAUPAUBR

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024